The stock of Venus Concept Inc. (NASDAQ:VERO) last traded at $0.19, down -5.00% from the previous session.
Data from the available sources indicates that Venus Concept Inc. (NASDAQ:VERO) is covered by 3 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.25 and a low of $0.75, we find $1.00. Given the previous closing price of $0.20, this indicates a potential upside of 400.0 percent. VERO stock price is now -34.04% away from the 50-day moving average and -51.48% away from the 200-day moving average. The market capitalization of the company currently stands at $12.46M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
In total, 0 analysts have assigned it a hold rating, and 3 have given it a buy rating. Brokers who have rated the stock have averaged $1.67 as their price target over the next twelve months.
With the price target of $2.50, Stifel recently initiated with Hold rating for Venus Concept Inc. (NASDAQ: VERO). On October 20, 2020, Ladenburg Thalmann recently initiated its ‘Buy’ rating on the stock quoting a target price of $6, while ‘BTIG Research’ rates the stock as ‘Buy’.
In other news, Natale Anthony, Director sold 51,431 shares of the company’s stock on Nov 29. The stock was sold for $12,503 at an average price of $0.24. Upon completion of the transaction, the Director now directly owns 641,507 shares in the company, valued at $0.12 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 28, Director Natale Anthony sold 51,428 shares of the business’s stock. A total of $13,680 was realized by selling the stock at an average price of $0.27. This leaves the insider owning 692,938 shares of the company worth $0.13 million. Insiders disposed of 257,143 shares of company stock worth roughly $48857.17 over the past 1 year. A total of 4.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in VERO stock. A new stake in Venus Concept Inc. shares was purchased by SVB FINANCIAL GROUP during the first quarter worth $30,000. NUVEEN ASSET MANAGEMENT, LLC invested $12,000 in shares of VERO during the first quarter. In the first quarter, JANE STREET GROUP, LLC acquired a new stake in Venus Concept Inc. valued at approximately $9,000. SUSQUEHANNA INTERNATIONAL GROUP, LLP acquired a new stake in VERO for approximately $8,000. TWO SIGMA INVESTMENTS, LP purchased a new stake in VERO valued at around $7,000 in the second quarter. In total, there are 44 active investors with 75.30% ownership of the company’s stock.
With an opening price of $0.1995 on Wednesday morning, Venus Concept Inc. (NASDAQ: VERO) set off the trading day. During the past 12 months, Venus Concept Inc. has had a low of $0.15 and a high of $1.62. As of last week, the company has a debt-to-equity ratio of 3.40, a current ratio of 3.10, and a quick ratio of 2.30. The fifty day moving average price for VERO is $0.2855 and a two-hundred day moving average price translates $0.3890 for the stock.
The latest earnings results from Venus Concept Inc. (NASDAQ: VERO) was released for Sep, 2022. According to the Medical Devices Company, earnings per share came in at -$0.22, missing analysts’ expectations of -$0.15 by -0.07. This compares to -$0.16 EPS in the same period last year. The net profit margin was -20.20% and return on equity was -71.80% for VERO. The company reported revenue of $21.54 million for the quarter, compared to $24.56 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -12.31 percent. For the current quarter, analysts expect VERO to generate $23.77M in revenue.
Venus Concept Inc.(VERO) Company Profile
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
